| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |